94 related articles for article (PubMed ID: 455286)
1. Effects of adriamycin and cyclophosphamide treatment on induction of macrophage cytotoxic function in mice.
Stoychkov JN; Schultz RM; Chirigos MA; Pavlidis NA; Goldin A
Cancer Res; 1979 Aug; 39(8):3014-7. PubMed ID: 455286
[TBL] [Abstract][Full Text] [Related]
2. Immune response of BALB/c X DBA/2F1 mice to a tumor allograft during pyran copolymer-induced tumor enhancement.
Schultz RM; Woods WA; Mohr SJ; Chirigos MA
Cancer Res; 1976 May; 36(5):1641-6. PubMed ID: 1268825
[TBL] [Abstract][Full Text] [Related]
3. In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide.
Schlick E; Ruffmann R; Chirigos MA; Welker RD; Herberman RB
Cancer Res; 1985 Mar; 45(3):1108-14. PubMed ID: 3871661
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
Fisher B; Gebhardt M
Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
[TBL] [Abstract][Full Text] [Related]
5. [Effect of BCG and cyclophosphamide on the antitumor activity of mouse peritoneal macrophages].
Gromov SA; Okulov VB; Voĭtenkov BO
Eksp Onkol; 1989; 11(3):63-6. PubMed ID: 2752946
[TBL] [Abstract][Full Text] [Related]
6. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemoimmunotherapy of cancer: influence of tumor burden and role of functional immune effector cells in mice.
Schlick E; Hewetson P; Ruffmann R
Cancer Res; 1986 Jul; 46(7):3378-83. PubMed ID: 3708572
[TBL] [Abstract][Full Text] [Related]
8. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
Avery TL; Roberts D
Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368
[TBL] [Abstract][Full Text] [Related]
9. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
Schultz RM; Tang JC; DeLong DC; Ades EW; Altom MG
Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909
[TBL] [Abstract][Full Text] [Related]
10. Tumoricidal effector mechanisms of murine Bacillus Calmette-Guérin-activated macrophages: mediation of cytolysis, mitochondrial respiration inhibition, and release of intracellular iron by distinct mechanisms.
Klostergaard J; Leroux ME; Ezell SM; Kull FC
Cancer Res; 1987 Apr; 47(8):2014-9. PubMed ID: 3828989
[TBL] [Abstract][Full Text] [Related]
11. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
Ujiie T
Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200
[TBL] [Abstract][Full Text] [Related]
12. Effect of pyran copolymer on activation of murine macrophages: evidence for incomplete activation by use of functional markers.
Adams DO; Johnson WJ; Marino PA; Dean JH
Cancer Res; 1983 Aug; 43(8):3633-7. PubMed ID: 6861134
[TBL] [Abstract][Full Text] [Related]
13. Pyran (MVE-5) reverses the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.
Rao VS; Mitchell MS
J Biol Response Mod; 1983; 2(1):67-80. PubMed ID: 6606020
[TBL] [Abstract][Full Text] [Related]
14. Association of macrophage activation with antitumor activity by synthetic and biological agents.
Schultz RM; Papamatheakis JD; Luetzeler J; Chirigos MA
Cancer Res; 1977 Sep; 37(9):3338-43. PubMed ID: 884678
[TBL] [Abstract][Full Text] [Related]
15. Immunological reactivity of the lung. IV. Effect of cyclophosphamide on alveolar macrophage cytotoxic effector function.
Hunninghake GW; Fauci AS
Clin Exp Immunol; 1977 Mar; 27(3):555-9. PubMed ID: 862243
[TBL] [Abstract][Full Text] [Related]
16. Macrophage involvement in the protective effect of pyran copolymer against the Madison lung carcinoma (M109).
Schultz RM; Papamatheakis JD; Luetzeler J; Ruiz P; Chirigos MA
Cancer Res; 1977 Feb; 37(2):358-64. PubMed ID: 832262
[TBL] [Abstract][Full Text] [Related]
17. Tumor cytokinetics in the presence of normal, alloimmune, or Bacillus Calmette-Guérin-activated host cells simultaneously assayed in vivo and in vitro.
Normann SJ; Cornelius J
Cancer Res; 1987 Apr; 47(8):2067-72. PubMed ID: 3828996
[TBL] [Abstract][Full Text] [Related]
18. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
Li LH; DeKoning TF; Wallace TL
Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
[TBL] [Abstract][Full Text] [Related]
19. Effect of maleic anhydride-divinyl ether copolymers on experimental M109 metastases and macrophage tumoricidal function.
Pavlidis NA; Schultz RM; Chirigos MA; Luetzeler J
Cancer Treat Rep; 1978 Nov; 62(11):1817-22. PubMed ID: 728899
[TBL] [Abstract][Full Text] [Related]
20. Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection.
James SL; Skamene E; Meltzer MS
J Immunol; 1983 Aug; 131(2):948-53. PubMed ID: 6863937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
